Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Structural Priming as a Treatment Component in Aphasia

NCT05415501 is registered in ClinicalTrials.gov with Purdue University as lead sponsor.

NCT NCT05415501
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05415501 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Structural Priming as a Treatment Component in Aphasia
Lead sponsor
Purdue University
Phase
Not applicable
Overall status
Recruiting
Start date
August 1, 2021
Completion date
May 30, 2026
Enrollment
104 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aphasia